Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment optionsActive cytomegalovirus infection in aortic smooth muscle cells from patients with abdominal aortic aneurysmA high red blood cell distribution width predicts failure of arteriovenous fistulaElimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplants.Host-derived smooth muscle cells accumulate in cardiac allografts: role of inflammation and monocyte chemoattractant protein 1.Cytomegalovirus Restructures Lipid Rafts via a US28/CDC42-Mediated Pathway, Enhancing Cholesterol Efflux from Host Cells.Steady-state plasma membrane expression of human cytomegalovirus gB is determined by the phosphorylation state of Ser900Human cytomegalovirus persistently infects aortic endothelial cells.Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependentHuman cytomegalovirus latency and reactivation - a delicate balance between the virus and its host's immune system.Role of alloimmunity in clinical transplantation.Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.High prevalence of human cytomegalovirus in carotid atherosclerotic plaques obtained from Russian patients undergoing carotid endarterectomyHuman cytomegalovirus infection is sensitive to the host cell DNA methylation state and alters global DNA methylation capacity.Viral infections and their impact on chronic renal allograft dysfunction.Detection of circulating hcmv-miR-UL112-3p in patients with glioblastoma, rheumatoid arthritis, diabetes mellitus and healthy controls.Welcome to Herpesviridae -- a new premier virology journal.RCMV increases intimal hyperplasia by inducing inflammation, MCP-1 expression and recruitment of adventitial cells to intimaThe human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteinsHuman cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells.Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic targetPoor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery.Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?High prevalence of cytomegalovirus infection in surgical intestinal specimens from infants with necrotizing enterocolitis and spontaneous intestinal perforation: A retrospective observational study.Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impactHuman cytomegalovirus persists in its host and attacks and avoids elimination by the immune system.Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infectionInflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus.HCMV microinfections in inflammatory diseases and cancer.Impaired direct priming of CD8 T cells by donor-derived cytomegalovirus following kidney transplantation.Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines.Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity.Is human cytomegalovirus a target in cancer therapy?Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology.Treatment of cytomegalovirus infections beyond acute disease to improve human health.Human antibody technology and the development of antibodies against cytomegalovirus.Cytomegalovirus driven immunosenescence-An immune phenotype with or without clinical impact?Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target?Human cytomegalovirus particles directly suppress CD4 T-lymphocyte activation and proliferation.Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients.
P50
Q26996612-B04B7331-1385-4435-BFC2-ADC1728020B7Q28304034-5242D810-62EB-4503-85CF-9801DFFF0AE5Q28483360-6D9E7369-5EAF-4959-B84B-7C3C860D0BECQ31043979-F66E5EA5-5EBB-464F-9C00-21DD0636BB59Q33399716-5CD11466-BC6B-4FED-B59B-14E048B64876Q33557172-CAAD3BF4-DC55-4A34-A0B7-2BE8432CB2E6Q33783566-40D925E9-1BF4-4652-B501-6172D2955E4CQ33785091-EB08DBDC-308A-4051-BB4A-4B5A3DF66CAAQ33852869-4C59A126-5D14-4B3C-A214-1DD101C92585Q33854329-DB25A39C-5808-4728-B051-868F609F2F10Q34188332-C8D1B078-EDDA-4329-8048-B5E246CFD920Q34212265-A30EB6D1-C41B-4F2B-BDAC-20B1A92E9832Q34253980-4F55450E-3BC4-460F-B085-52F47B0FDD00Q34275714-58FDC160-1304-4D2F-9803-5D152ECB7B3FQ34388857-E6C3F61E-ABE3-4EFB-9D51-5679F2472E3AQ34612095-C5CAC7AB-FFF1-48BB-984F-7B1EBC98E963Q34631642-F95D9ABC-AE4F-440D-989B-32118F92DAC8Q34712927-B99D570D-D302-4A38-A9FB-D5DC62794639Q34858638-E64708DF-AB27-4E43-89FE-A99104714540Q35024214-FCF54417-705C-41FA-9935-A37FD4ADBF23Q35370135-BCF70F1B-5E5A-4EB4-B2A7-DADBEE5AF07FQ36060293-DB9ED8B0-BCD3-4DBB-9A3E-453AFE399D8AQ36395715-BD73D796-4273-4977-A182-06514D0EEF17Q36410537-6A9D7365-C268-40A7-9924-B23FDFE2AD4BQ36472483-7437BDBB-B3ED-4115-A84E-B363EF5C8690Q36574961-43F52E0A-CDFB-4188-AB6D-03D0C5F4CD86Q36647204-9053B9FE-73BE-42D4-AF6A-7C9CE20B455EQ36777192-1E6D7F4D-43E3-45A2-AB42-AFA5A5F05832Q37046927-2486D09F-F6A6-4A6C-8053-7ACE8935E6D6Q37202784-D4E45496-106C-4ED6-9B4F-1B82245E03FEQ37376709-258D033D-33B8-4FD7-B9CA-E1AD7315DAD2Q37444835-B1A5F233-F0EC-4E1D-8C21-BC20F1561A09Q37975925-CA25D4F9-3111-497C-9DC9-5811F98A9FFCQ38053067-563F46D9-8466-450F-9857-7411B632F739Q38176940-643A8FB0-F517-48F9-8461-9666B522D37BQ38388523-241F3196-267A-4B1B-8BFF-652EB514C0FCQ38869198-648A1D48-F4AA-4B8A-BA50-A122FF66244CQ39153890-7152D131-AA28-42FD-8C80-EF8D26B97D19Q39189976-F4DC3340-8740-4086-A8CF-38921EB8AA72Q39279856-EA01AB9A-41E4-45B0-AF6D-D505F4359BB8
P50
description
investigador
@es
researcher
@en
svensk läkare, immunolog och professor
@sv
wetenschapper
@nl
스웨덴 면역학자
@ko
name
Cecilia Söderberg-Nauclér
@ast
Cecilia Söderberg-Nauclér
@en
Cecilia Söderberg-Nauclér
@es
Cecilia Söderberg-Nauclér
@nl
Cecilia Söderberg-Nauclér
@sv
세실리아 쇠데르베리나우클레르
@ko
type
label
Cecilia Söderberg-Nauclér
@ast
Cecilia Söderberg-Nauclér
@en
Cecilia Söderberg-Nauclér
@es
Cecilia Söderberg-Nauclér
@nl
Cecilia Söderberg-Nauclér
@sv
세실리아 쇠데르베리나우클레르
@ko
altLabel
C Söderberg-Nauclér
@en
C. Söderberg-Nauclér
@en
Söderberg-Nauclér C
@en
Söderberg-Nauclér C.
@en
Söderberg-Nauclér
@en
prefLabel
Cecilia Söderberg-Nauclér
@ast
Cecilia Söderberg-Nauclér
@en
Cecilia Söderberg-Nauclér
@es
Cecilia Söderberg-Nauclér
@nl
Cecilia Söderberg-Nauclér
@sv
세실리아 쇠데르베리나우클레르
@ko
P106
P21
P214
4626147872007075170006
P31
P39
P496
0000-0001-8955-3610
P735
P7859
viaf-4626147872007075170006